Talk:MitoFit news: Difference between revisions

Revision as of 06:37, 2 September 2015

... Thyfault JP (with question on Copenhagen)
01#. 2015-07-##: Heart failure with preserved ejection fraction induces molecular, mitochondrial, histological, and functional alterations in rat respiratory and limb skeletal muscle. » Bowen 2015 Eur J Heart Fail

01#. 2015-07-##: » Spinazzi 2014 Neuropathol Appl Neurobiol (suggestions by Georg)

@@ Line 2: / Line 2: @@
 === Ready ===
-[[File:TIP2k-Needle Safety Support overview.JPG|right|100px|link=TIP2k-Module|TIP2k]]
-* '''014'''. 2015-09-03: '''Defining mt-hypoxia at steady-states''', with the [[NextGen-O2k]]: » '''[[Harrison 2015 J Appl Physiol]]'''
-: Open Innovation: the NextGen-O2k is not yet in series production, but some special innovations are now available:
-:» '''[[TIP2k-Module]]''' with 200 µl (new) or 500 µl syringes, for steady-state hypoxia and more.
-:» [[O2k-Titration_Set |'''OROBOROS racks''']] make experiments with SUIT protocols more convenient.